Edition:
United Kingdom

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

43.81USD
23 Jan 2018
Change (% chg)

$0.65 (+1.51%)
Prev Close
$43.16
Open
$43.07
Day's High
$44.18
Day's Low
$43.07
Volume
11,408
Avg. Vol
7,390
52-wk High
$58.36
52-wk Low
$41.95

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $350.55
Shares Outstanding(Mil.): 7.16
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.62
EPS (TTM): -- -- --
ROI: -- 3.19 10.61
ROE: -- 4.52 14.21

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

10 Nov 2017

BRIEF-BioSpecifics Technologies reports Q2 earnings per share $0.36

* BioSpecifics Technologies Corp reports second quarter 2017 financial results

09 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $141.83 -6.31
Novartis AG (NOVN.S) CHF83.60 --
Pfizer Inc. (PFE.N) $36.82 -0.11
Roche Holding Ltd. (ROG.S) CHF236.90 --
Roche Holding Ltd. (RO.S) CHF238.60 +0.20
Merck & Co., Inc. (MRK.N) $61.70 +0.45
Bayer AG (BAYGn.DE) €109.22 --
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €71.18 --
GlaxoSmithKline plc (GSK.L) 1,364.40 +9.20

Earnings vs. Estimates